(Q49052685)

18 February 2018

title

Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. (English)

1 reference

18 February 2018

1 reference

Ströhle A

1

1 reference

18 February 2018

publication date

1 November 2000

1 reference

18 February 2018

Journal of Psychiatric Research

published in

1 reference

18 February 2018

volume

34

1 reference

18 February 2018

issue

6

1 reference

18 February 2018

page(s)

439-442

1 reference

18 February 2018

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

The diagnostic utility of lactate sensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Measurement of lactate-induced panic and anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Psychophysiological factors in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Panic attacks during placebo procedures in the laboratory. Physiology and symptomatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

A neuroanatomical hypothesis for panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Neuroanatomical hypothesis of panic disorder, revised

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Panic disorder and quality of life: variables predictive of functional impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Lactate provocation of panic attacks. II. Biochemical and physiological findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Sodium lactate infusions and panic attacks: a review and critique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Lactate Metabolism in Anxiety Neurosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Effect of flumazenil in lactate-sensitive patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

The placebo effect: an unpopular topic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

The cross-national epidemiology of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

Is the course of panic disorder the same in women and men?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2800%2900039-X

10.1016/S0022-3956(00)00039-X

7 January 2021

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

11165311

1 reference

18 February 2018